61
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients
Condition(s): Hematologic Neoplasms; Neoplasms Last Updated: August 24, 2010Completed
6746 Clinical Trials for: Hematologic Neoplasms, Page 4 of 338
Hide Studies Not Seeking New Volunteers
62
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
Condition(s): Hematologic Neoplasms; Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Multiple Myeloma Last Updated: January 31, 2013Recruiting
63
Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients
Condition(s): Breast Cancer; Hematologic Neoplasms Last Updated: May 10, 2013Completed
64
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Condition(s): Lymphoma, T-Cell; Mycosis Fungoides; Hematologic Neoplasms Last Updated: July 27, 2012Terminated
65
Allogeneic Hematopoietic Stem Cell Transplantation
Condition(s): Solid Tumors; Hematologic Neoplasms Last Updated: January 18, 2011Recruiting
66
Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion
Condition(s): Hematologic Neoplasms; Relapse Last Updated: January 21, 2011Completed
67
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
Condition(s): Graft vs Host Disease; Hematologic Neoplasms; Lymphoma; Myelodysplastic Syndromes; Myeloid Leukemia Last Updated: March 3, 2008Completed
68
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Condition(s): Hematologic Neoplasms; Bone Marrow Neoplasms; Non-Hodgkin's Lymphoma Last Updated: July 18, 2012Completed
69
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
Condition(s): Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders Last Updated: May 10, 2013Recruiting
70
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
Condition(s): Leukemia; Lymphoma; Hodgkin's Disease; Hematologic Neoplasms; Multiple Myeloma; Carcinoma, Renal Cell Last Updated: March 16, 2011Terminated
71
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
Condition(s): Hematologic Neoplasms; Leukemia; Lymphoma; Multiple Myeloma; Hodgkin's Disease Last Updated: March 11, 2011Recruiting
72
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
Condition(s): Hematologic Neoplasms Last Updated: April 2, 2012Completed
73
Intra-bone Cord Blood Transplantation
Condition(s): Hematologic Neoplasms Last Updated: April 5, 2013Recruiting
74
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies
Condition(s): Hematologic Neoplasms Last Updated: February 19, 2013Completed
75
Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation
Condition(s): Hematologic Neoplasms Last Updated: January 16, 2013Completed
76
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
Condition(s): Hematologic Neoplasms Last Updated: March 14, 2013Active, not recruiting
77
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Condition(s): Leukemia; Myelodysplastic Syndromes Last Updated: August 3, 2012Active, not recruiting
78
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes Last Updated: February 14, 2013Active, not recruiting
79
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Secondary Myelofibrosis Last Updated: February 16, 2012Recruiting
80
Personalized Cancer Therapy
Condition(s): Invasive Cancer; Sarcoma; Hematologic Cancer Last Updated: March 6, 2013Recruiting
